OTTAWA, ON, Jan. 9, 2025 /CNW/ - Esphera SynBio, a pre-clinical stage synthetic biology company, today announced a new project aimed at advancing next-generation mRNA vaccines. Using its ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback